InsiderClue
Insiders · Profile

Bolzon Bradley J PhD

Director at CRISPR Therapeutics · Director at Monte Rosa Therapeutics · Director at Black Diamond Therapeutics. Filing since 24 Oct 2016. CIK 0001354345

CRSP CRISPR Therapeutics AG Director · 34 trades GLUE Monte Rosa Therapeutics, Inc. Director · 1 trade BDTX Black Diamond Therapeutics, Inc. Director · 28 trades
Company
Date
Role
Action
Shares
Amount
Of holding
CRSP CRISPR Therapeutics AG
19 Jul 2021
Director
Sold, plan not stated
10,000
$1.26M
6.3%
CRSP CRISPR Therapeutics AG
29 Jun 2021
Director
Sold, plan not stated
47,536
$7.11M
100%
CRSP CRISPR Therapeutics AG
28 Jun 2021
Director
Sold, plan not stated
20,375
$3.11M
100%
GLUE Monte Rosa Therapeutics, Inc.
28 Jun 2021
Director
Bought
157,895
$3.00M
8.1%
CRSP CRISPR Therapeutics AG
28 Jun 2021
Director
Sold, plan not stated
10,000
$1.52M
5.9%
CRSP CRISPR Therapeutics AG
11 Jun 2021
Director
Sold, plan not stated
10,000
$1.27M
32.9%
CRSP CRISPR Therapeutics AG
22 Mar 2021
Director
Sold, plan not stated
30,374
$4.02M
50.0%
CRSP CRISPR Therapeutics AG
19 Feb 2021
Director
Sold, plan not stated
171,003
$25.50M
50.3%
CRSP CRISPR Therapeutics AG
16 Dec 2020
Director
Sold, plan not stated
7,648
$1.14M
100%
CRSP CRISPR Therapeutics AG
16 Dec 2020
Director
Sold, plan not stated
7,352
$1.10M
2.1%
CRSP CRISPR Therapeutics AG
10 Dec 2020
Director
Sold, plan not stated
33,000
$4.73M
9.5%
CRSP CRISPR Therapeutics AG
7 Dec 2020
Director
Sold, plan not stated
171,004
$26.42M
33.0%
BDTX Black Diamond Therapeutics, Inc.
30 Nov 2020
Director
Sold, plan not stated
10,393
$344.51K
1.2%
BDTX Black Diamond Therapeutics, Inc.
19 Nov 2020
Director
Sold, plan not stated
130,017
$4.29M
11.8%
BDTX Black Diamond Therapeutics, Inc.
18 Nov 2020
Director
Sold, plan not stated
536
$17.74K
0.1%
BDTX Black Diamond Therapeutics, Inc.
17 Nov 2020
Director
Sold, plan not stated
4,194
$138.61K
0.4%
BDTX Black Diamond Therapeutics, Inc.
16 Nov 2020
Director
Sold, plan not stated
200
$6.60K
0.0%
BDTX Black Diamond Therapeutics, Inc.
13 Nov 2020
Director
Sold, plan not stated
4,500
$151.98K
0.5%
BDTX Black Diamond Therapeutics, Inc.
12 Nov 2020
Director
Sold, plan not stated
15,598
$532.64K
1.6%
BDTX Black Diamond Therapeutics, Inc.
11 Nov 2020
Director
Sold, plan not stated
12,617
$438.22K
1.3%
BDTX Black Diamond Therapeutics, Inc.
10 Nov 2020
Director
Sold, plan not stated
26,966
$912.14K
2.7%
BDTX Black Diamond Therapeutics, Inc.
9 Nov 2020
Director
Sold, plan not stated
6,300
$208.25K
0.6%
BDTX Black Diamond Therapeutics, Inc.
6 Nov 2020
Director
Sold, plan not stated
3,100
$102.70K
0.3%
BDTX Black Diamond Therapeutics, Inc.
5 Nov 2020
Director
Sold, plan not stated
8,848
$293.29K
0.9%
BDTX Black Diamond Therapeutics, Inc.
4 Nov 2020
Director
Sold, plan not stated
2,500
$82.84K
0.3%
BDTX Black Diamond Therapeutics, Inc.
27 Oct 2020
Director
Sold, plan not stated
800
$26.43K
0.1%
BDTX Black Diamond Therapeutics, Inc.
26 Oct 2020
Director
Sold, plan not stated
8,103
$269.87K
0.8%
BDTX Black Diamond Therapeutics, Inc.
19 Oct 2020
Director
Sold, plan not stated
4,233
$141.51K
0.4%
BDTX Black Diamond Therapeutics, Inc.
16 Oct 2020
Director
Sold, plan not stated
8,713
$292.52K
0.9%
BDTX Black Diamond Therapeutics, Inc.
15 Oct 2020
Director
Sold, plan not stated
2,800
$92.50K
0.3%
BDTX Black Diamond Therapeutics, Inc.
14 Oct 2020
Director
Sold, plan not stated
5,501
$182.03K
0.5%
BDTX Black Diamond Therapeutics, Inc.
13 Oct 2020
Director
Sold, plan not stated
11,739
$391.98K
1.2%
BDTX Black Diamond Therapeutics, Inc.
12 Oct 2020
Director
Sold, plan not stated
400
$13.24K
0.0%
BDTX Black Diamond Therapeutics, Inc.
9 Oct 2020
Director
Sold, plan not stated
3,800
$127.93K
0.4%
BDTX Black Diamond Therapeutics, Inc.
8 Oct 2020
Director
Sold, plan not stated
18,425
$616.75K
1.8%
BDTX Black Diamond Therapeutics, Inc.
7 Oct 2020
Director
Sold, plan not stated
27,836
$934.08K
2.6%
BDTX Black Diamond Therapeutics, Inc.
6 Oct 2020
Director
Sold, plan not stated
18,090
$601.65K
1.7%
CRSP CRISPR Therapeutics AG
18 Sep 2020
Director
Sold, plan not stated
3,035
$263.64K
0.6%
CRSP CRISPR Therapeutics AG
16 Sep 2020
Director
Sold, plan not stated
8,965
$779.78K
1.7%
CRSP CRISPR Therapeutics AG
14 Sep 2020
Director
Sold, plan not stated
1,155
$98.05K
0.2%
CRSP CRISPR Therapeutics AG
10 Sep 2020
Director
Sold, plan not stated
22,845
$1.95M
4.1%
CRSP CRISPR Therapeutics AG
1 Sep 2020
Director
Sold, plan not stated
60,000
$5.55M
100%
BDTX Black Diamond Therapeutics, Inc.
11 Aug 2020
Director
Sold, plan not stated
7,575
$250.59K
0.7%
BDTX Black Diamond Therapeutics, Inc.
10 Aug 2020
Director
Sold, plan not stated
6,217
$205.40K
0.5%
CRSP CRISPR Therapeutics AG
6 Jul 2020
Director
Sold, plan not stated
20,000
$1.65M
3.5%
CRSP CRISPR Therapeutics AG
23 Jun 2020
Director
Sold, plan not stated
10,000
$753.45K
1.7%
CRSP CRISPR Therapeutics AG
22 Jun 2020
Director
Sold, plan not stated
10,000
$725.07K
1.7%
BDTX Black Diamond Therapeutics, Inc.
3 Feb 2020
Director
Bought
894,736
$17.00M
15.1%
CRSP CRISPR Therapeutics AG
19 Nov 2019
Director
Sold, plan not stated
28,255
$1.90M
4.5%
CRSP CRISPR Therapeutics AG
19 Nov 2019
Director
Sold, plan not stated
13,745
$926.61K
100%
CRSP CRISPR Therapeutics AG
30 Oct 2019
Director
Sold, plan not stated
21,000
$1.09M
60.4%
CRSP CRISPR Therapeutics AG
15 May 2018
Director
Sold, plan not stated
44,000
$2.55M
6.4%
CRSP CRISPR Therapeutics AG
8 May 2018
Director
Sold, plan not stated
9,241
$467.07K
21.0%
CRSP CRISPR Therapeutics AG
7 May 2018
Director
Sold, plan not stated
119,709
$6.03M
77.4%
CRSP CRISPR Therapeutics AG
30 Apr 2018
Director
Sold, plan not stated
30,566
$1.54M
44.5%
CRSP CRISPR Therapeutics AG
27 Apr 2018
Director
Sold, plan not stated
11,648
$582.66K
23.1%
CRSP CRISPR Therapeutics AG
26 Apr 2018
Director
Sold, plan not stated
210,610
$10.55M
84.3%
CRSP CRISPR Therapeutics AG
24 Apr 2018
Director
Sold, plan not stated
22,841
$1.16M
33.9%
CRSP CRISPR Therapeutics AG
23 Apr 2018
Director
Sold, plan not stated
101,994
$5.17M
69.3%
CRSP CRISPR Therapeutics AG
22 Dec 2017
Director
Sold, plan not stated
26,016
$528.24K
48.4%
CRSP CRISPR Therapeutics AG
27 Nov 2017
Director
Sold, plan not stated
200
$4.05K
0.4%
CRSP CRISPR Therapeutics AG
24 Nov 2017
Director
Sold, plan not stated
1,507
$30.45K
2.7%
CRSP CRISPR Therapeutics AG
24 Oct 2016
Director
Bought
161,000
$2.25M
4.1%
63 decisions on file.